Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3221

1.

Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.

Guan M, Keaton JM, Dimitrov L, Hicks PJ, Xu J, Palmer ND, Ma L, Das SK, Chen YI, Coresh J, Fornage M, Franceschini N, Kramer H, Langefeld CD, Mychaleckyj JC, Parekh RS, Post WS, Rasmussen-Torvik LJ, Rich SS, Rotter JI, Sedor JR, Thornley-Brown D, Tin A, Wilson JG, Freedman BI, Bowden DW, Ng MCY; FIND Consortium.

Hum Genomics. 2019 May 15;13(1):21. doi: 10.1186/s40246-019-0205-7.

2.

CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.

Cunningham EL, McGuinness B, McAuley DF, Toombs J, Mawhinney T, O'Brien S, Beverland D, Schott JM, Lunn MP, Zetterberg H, Passmore AP.

Ann Surg. 2019 Jun;269(6):1200-1205. doi: 10.1097/SLA.0000000000002684.

PMID:
31082921
3.

Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL.

Strati P, Takahashi K, Peterson CB, Keating MJ, Thompson PA, Daver NG, Jain N, Burger JA, Estrov Z, O'Brien SM, Kantarjian HM, Wierda WG, Futreal PA, Ferrajoli A.

Blood Adv. 2019 May 14;3(9):1533-1539. doi: 10.1182/bloodadvances.2019031336.

4.

Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer.

O'Brien SM, Klampatsa A, Thompson JC, Martinez MC, Hwang WT, Rao AS, Standalick JE, Kim S, Cantu E, Litzky LA, Singhal S, Eruslanov EB, Moon EK, Albelda SM.

Cancer Immunol Res. 2019 May 3. doi: 10.1158/2326-6066.CIR-18-0713. [Epub ahead of print]

PMID:
31053597
5.

von Willebrand Disease in Pediatrics: Evaluation and Management.

O'Brien SH, Saini S.

Hematol Oncol Clin North Am. 2019 Jun;33(3):425-438. doi: 10.1016/j.hoc.2019.01.010. Review.

PMID:
31030811
6.

An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury.

O'Brien S, Metcalf K, Batchelor J.

Clin Neuropsychol. 2019 Apr 25:1-20. doi: 10.1080/13854046.2019.1598501. [Epub ahead of print]

PMID:
31020899
7.

Whole Genome Sequencing and Re-sequencing of the Sable Antelope (Hippotragus niger): A Resource for Monitoring Diversity in ex Situ and in Situ Populations.

Koepfli KP, Tamazian G, Wildt D, Dobrynin P, Kim C, Frandsen PB, Godinho R, Yurchenko AA, Komissarov A, Krasheninnikova K, Kliver S, Kolchanova S, Gonçalves M, Carneiro M, Vaz Pinto P, Ferrand N, Maldonado JE, Ferrie GM, Chemnick L, Ryder OA, Johnson WE, Comizzoli P, O'Brien SJ, Pukazhenthi BS.

G3 (Bethesda). 2019 Apr 18. pii: g3.400084.2019. doi: 10.1534/g3.119.400084. [Epub ahead of print]

8.

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia.

Sharman JP, Coutre SE, Furman RR, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn IW, Ghia P, Eradat H, Ervin T, Lamanna N, Coiffier B, Pettitt AR, Ma S, Tausch E, Cramer P, Huang J, Mitra S, Hallek M, O'Brien SM, Stilgenbauer S.

J Clin Oncol. 2019 Apr 17:JCO1801460. doi: 10.1200/JCO.18.01460. [Epub ahead of print]

PMID:
30995176
9.

Carfentrazone-ethyl resistance in an Amaranthus tuberculatus population is not mediated by amino acid alterations in the PPO2 protein.

Obenland OA, Ma R, O'Brien SR, Lygin AV, Riechers DE.

PLoS One. 2019 Apr 15;14(4):e0215431. doi: 10.1371/journal.pone.0215431. eCollection 2019.

10.

Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.

Jabbour EJ, Sasaki K, Ravandi F, Short NJ, Garcia-Manero G, Daver N, Kadia T, Konopleva M, Jain N, Cortes J, Issa GC, Jacob J, Kwari M, Thompson P, Garris R, Pemmaraju N, Yilmaz M, O'Brien SM, Kantarjian HM.

Cancer. 2019 Apr 15. doi: 10.1002/cncr.32139. [Epub ahead of print]

PMID:
30985931
11.

International Forum on Occult hepatitis B infection and transfusion safety.

Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison KL, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'Brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M.

Vox Sang. 2019 May;114(4):e1-e35. doi: 10.1111/vox.12743. Epub 2019 Apr 10. No abstract available.

PMID:
30972757
12.

Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort.

Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R.

J Pediatr. 2019 Apr 5. pii: S0022-3476(19)30239-2. doi: 10.1016/j.jpeds.2019.02.015. [Epub ahead of print]

PMID:
30961988
13.

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.

O'Brien SP, Swanstrom AE, Pegu A, Ko SY, Immonen TT, Del Prete GQ, Fennessey CM, Gorman J, Foulds KE, Schmidt SD, Doria-Rose N, Williamson C, Hatziioannou T, Bieniasz PD, Li H, Shaw GM, Mascola JR, Koup RA, Kwong PD, Lifson JD, Roederer M, Keele BF.

PLoS Pathog. 2019 Apr 3;15(4):e1007632. doi: 10.1371/journal.ppat.1007632. eCollection 2019 Apr.

14.

Simulation TRaining for Operative vaginal Birth Evaluation: study protocol for an observational stepped-wedge interrupted time-series study (STROBE).

O'Brien S, Lenguerrand E, Jordan S, Cornthwaite K, Burden C, Timlin L, Siassakos D.

BMC Pregnancy Childbirth. 2019 Apr 2;19(1):109. doi: 10.1186/s12884-019-2222-x.

15.

THROMBOTECT takes the lead.

Male C, O'Brien SH, Mitchell L.

Haematologica. 2019 Apr;104(4):644-645. doi: 10.3324/haematol.2018.209528. No abstract available.

16.

Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition.

Gabbasov R, Benrubi ID, O'Brien SW, Krais JJ, Johnson N, Litwin S, Connolly DC.

Cancer Biol Ther. 2019 Mar 30:1-11. doi: 10.1080/15384047.2019.1595279. [Epub ahead of print]

PMID:
30929564
17.

CRISPR-mediated gene editing for the surgeon scientist.

O'Brien SJ, Ekman MB, Manek S, Galandiuk S.

Surgery. 2019 Mar 25. pii: S0039-6060(19)30062-5. doi: 10.1016/j.surg.2019.01.030. [Epub ahead of print] Review.

PMID:
30922545
18.

Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study.

Kantarjian HM, DeAngelo DJ, Stelljes M, Liedtke M, Stock W, Gökbuget N, O'Brien SM, Jabbour E, Wang T, Liang White J, Sleight B, Vandendries E, Advani AS.

Cancer. 2019 Mar 28. doi: 10.1002/cncr.32116. [Epub ahead of print]

PMID:
30920645
19.

Foot drop following primary total hip arthroplasty.

O'Brien S, Gallagher N, Spence D, Bennett D, Dennison J, Beverland DE.

Hip Int. 2019 Mar 26:1120700019835454. doi: 10.1177/1120700019835454. [Epub ahead of print]

PMID:
30912466
20.

Genome-wide sequence analyses of ethnic populations across Russia.

Zhernakova DV, Brukhin V, Malov S, Oleksyk TK, Koepfli KP, Zhuk A, Dobrynin P, Kliver S, Cherkasov N, Tamazian G, Rotkevich M, Krasheninnikova K, Evsyukov I, Sidorov S, Gorbunova A, Chernyaeva E, Shevchenko A, Kolchanova S, Komissarov A, Simonov S, Antonik A, Logachev A, Polev DE, Pavlova OA, Glotov AS, Ulantsev V, Noskova E, Davydova TK, Sivtseva TM, Limborska S, Balanovsky O, Osakovsky V, Novozhilov A, Puzyrev V, O'Brien SJ.

Genomics. 2019 Mar 19. pii: S0888-7543(18)30741-9. doi: 10.1016/j.ygeno.2019.03.007. [Epub ahead of print]

PMID:
30902755

Supplemental Content

Loading ...
Support Center